MaxCyte (MXCT)
(Delayed Data from NSDQ)
$3.74 USD
-0.06 (-1.58%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.74 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 50.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.53 |
Next Year | -0.46 |
EPS (TTM) | -0.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.75M | 8.35M | 34.15M | 43.85M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 7.80M | 8.50M | 35.10M | 47.10M |
Low Estimate | 7.70M | 8.20M | 33.20M | 40.60M |
Year ago Sales | 8.58M | 9.04M | 41.29M | 34.15M |
Year over Year Growth Est. | -9.67% | -7.63% | -17.29% | 28.40% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.14 | -0.53 | -0.46 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.15 | -0.15 | -0.59 | -0.54 |
High Estimate | -0.12 | -0.12 | -0.48 | -0.38 |
Low Estimate | -0.15 | -0.15 | -0.59 | -0.54 |
Year ago EPS | -0.11 | -0.10 | -0.37 | -0.53 |
Year over Year Growth Est. | -27.27% | -40.00% | -43.24% | 12.58% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 3 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.14 | -0.53 | -0.46 |
7 Days Ago | -0.14 | -0.14 | -0.53 | -0.46 |
30 Days Ago | -0.14 | -0.14 | -0.51 | -0.46 |
60 Days Ago | NA | NA | -0.48 | NA |
90 Days Ago | NA | NA | -0.48 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.14 | -0.51 | -0.46 |
Zacks Consensus Estimate | -0.14 | -0.14 | -0.53 | -0.46 |
Earnings ESP | 0.00% | 0.00% | 3.17% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.11 | -0.10 | -0.11 | NA |
Estimate | -0.10 | -0.10 | -0.10 | -0.11 | NA |
Difference | 0.05 | -0.01 | 0.00 | 0.00 | 0.01 |
Surprise | 50.00% | -10.00% | 0.00% | 0.00% | 10.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more